PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97777905 |
Filing Date: 02/02/2023 |
Input Field |
Entered |
SERIAL NUMBER | 97777905 |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\977\779\97777905\xml1 \ APP0002.JPG |
SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | Kite |
COLOR MARK | YES |
COLOR(S) CLAIMED (If applicable) |
The color(s) blue, light blue, and red is/are claimed as a feature of the mark. |
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of a stylized design of a kite in light blue, blue, and red entering the top left corner of the screen, swooping to the bottom right corner, looping up to the top center and then gliding off the screen through the bottom, and swooping back onto the screen from the bottom left corner and gliding toward the center of the screen. The kite comes to a stop in the center of the screen where the wording "KITE" appears. The mark is a motion mark. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 940 x 754 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Kite Pharma, Inc. |
*MAILING ADDRESS | 2400 Broadway |
*CITY | Santa Monica |
*STATE (Required for U.S. applicants) |
California |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
90404 |
*EMAIL ADDRESS | XXXX |
WEBSITE ADDRESS | www.kitepharma.com |
LEGAL ENTITY INFORMATION | |
TYPE | corporation |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Delaware |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
INTERNATIONAL CLASS | 040 |
*IDENTIFICATION | Custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy |
FILING BASIS | SECTION 1(b) |
INTERNATIONAL CLASS | 044 |
*IDENTIFICATION | Providing medical information; providing a web site featuring medical information; providing medical information and advisory services; collection and preservation of biological tissue, blood and cells |
FILING BASIS | SECTION 1(b) |
INTERNATIONAL CLASS | 045 |
*IDENTIFICATION | Providing patient advocate services in the field of the treatment of diseases and disorders |
FILING BASIS | SECTION 1(b) |
ADDITIONAL STATEMENTS SECTION | |
DISCLAIMER | No claim is made to the exclusive right to use KITE apart from the mark as shown. |
MISCELLANEOUS STATEMENT | The applicant hereby attaches a video displaying the mark in motion. |
MISCELLANEOUS FILE NAME(S) | |
ORIGINAL FILE | APPLICANT-SUPPLIED FILE (SOUND/MOTION) |
ATTORNEY INFORMATION | |
NAME | Gretchen R. Stroud |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Gilead Sciences, Inc. |
STREET | 333 Lakeside Drive |
CITY | Foster City |
STATE | California |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 94404 |
EMAIL ADDRESS | trademarks@gilead.com |
OTHER APPOINTED ATTORNEY | Lori Mayall, Jack Wessel, Cynthia Smuzynska, Shelley Lai |
CORRESPONDENCE INFORMATION | |
NAME | Gretchen R. Stroud |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@gilead.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | tmteam@gilead.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Standard |
NUMBER OF CLASSES | 3 |
APPLICATION FOR REGISTRATION PER CLASS | 350 |
*TOTAL FEES DUE | 1050 |
*TOTAL FEES PAID | 1050 |
SIGNATURE INFORMATION | |
SIGNATURE | /cynthia smuzynska/ |
SIGNATORY'S NAME | Cynthia Smuzynska |
SIGNATORY'S POSITION | Sr. Counsel, IP |
SIGNATORY'S PHONE NUMBER | 650-522-5563 |
DATE SIGNED | 02/01/2023 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 97777905 |
Filing Date: 02/02/2023 |
The applicant's current Correspondence Information: |
Gretchen R. Stroud |
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@gilead.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tmteam@gilead.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|